Article Text

PDF

GW23-e2158
THE STUDY OF BONE MARROW MESENCHYMAL STEM CELLS GENE MODIFIED BY RECOMBINANT ADENO-ASSOCIATED VIRUS-9 COMBINED WITH PDGF-B IN VITRO
  1. Ma Xiang,
  2. Yao Yong-zhao,
  3. Zhao Ai-chao,
  4. Yuan Qing-hua,
  5. Lui Fen,
  6. Cheng Bang-dang,
  7. Ma Yi-tong
  1. First Affiliated Hospital of Xinjiang Medical University

    Abstract

    Objectives To explore the feasibility, stability and safety of using recombinant adeno-associated virus-9 which contained platelet-derived growth factor-B (rAAV9-PDGF-B) transduction to bone marrow mesenchymal stem cells in vitro.

    Methods Bone marrow mesenchymal stem cells (MSCs) were transduced with rAAV9-eGFP at MOI=1×106, and GFP expression was detected by converted fluorescence microscope. Experimental group: MSCs were transduced with rAAV9-PDGF-B, control group: MSCs were untreated. Collected stem cells from different times after transduction, respectively at 3 days, 6 days, 14 days, 21 days, 28 days. Proteins were extracted from the cells for Western blot analyse and observed the expression of PDGF-B, the transfection efficiency of after transduction 6 days and 21 days were measured by cell immunofluorescence. Alamar Blue assays were used to evaluate the safety of rAAV9-PDGF-B transduction to cardiomyocytes.

    Results After transduction (rAAV9-eGFP) 48 h, only individual cells own GFP, however the expression of GFP was gradually enhanced, 5–6 days reached a peak, and then GFP expression was began to fade. Cells of control group did not found the expression of PDGF-B, cells of experimental group were expressed PDGF-B after transduction 3 days (PDGF-B/GAPDH=15.6±1.1%), after 6 days reached a peak (63.7±2.7%), after 14 days (46.6±1.1%), after 21 days (34.5±1.2%), after 28 days (34.4±1.9%). By Statistical Analysis, the expression of PDGF-B in control group compared to experimental group p<0.01). Compared to each times in experimental group, pDGF-B level in 3 days was lower than other times, the level of 6 days was the highest. Moreover, there was no statistical significant difference between the level of 21 days and 28 days (p=1.0). Cell immunofluorescence showed that the transfection efficiency of after transduction 6 days and 21 days, was 65.7±2.6% and 39.6±1.8% p<0.01), the transfection efficiency of 6 days was higher than 21 days. Alamar Blue assays, which evaluated the toxicity of rAAV9-PDGF-B transduction to MSCs, showed that the reduction ratios of cardiomyocytes at different times were all close to 1.0, there was no statistical significant difference in each times.

    Conclusions rAAV9-PDGF-B could effectively transduce MSCs cultured in vitro and persistently express PDGF-B gene at least 28 days. Furthermore, rAAV9-PDGF-B was no significant toxic effects on MSCs.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.